Publications by authors named "Kirsten M Scott"

23Publications

Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.

Brain Behav Immun 2020 Jul 30;87:473-488. Epub 2020 Jan 30.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2020.01.018DOI Listing
July 2020

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Neurol Genet 2019 Aug 9;5(4):e348. Epub 2019 Jul 9.

Laboratory of Neurogenetics (H.I., C.B., H.L.L., F.F., D.G.H., A.B.S., M.A.N.), National Institute on Aging, National Institutes of Health, Bethesda; Data Tecnica International (H.I., M.A.N.), Glen Echo, MD; Precision Neurology Program (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Neurogenomics Laboratory (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Ann Romney Center for Neurologic Diseases (G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; The Norwegian Centre for Movement Disorders (J.M.-G., G.A.), Stavanger University Hospital; Department of Chemistry (J.M.-G., G.A.), Bioscience and Environmental Engineering, University of Stavanger, Norway; Assistance-Publique Hôpitaux de Paris (J.-C.C.), ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (L.P., M.T.), Oslo University Hospital, Norway; Department of Neurology (M.N., B.R.B., B.P.W.), Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Michael J Fox Foundation (S.J.H.), New York; Translational Genome Sciences (K.-D.H.N, K.E.), Biogen, Cambridge, MA; Department of Neurology University of Pennsylvania (J.R.), Philadelphia, PA; Department of Biostatistics and Computational Biology (S.E.), University of Rochester, NY; Department of Computer Science (F.F.), University of Illinois Urbana-Champaign; Department of Neurology (P.A.), Center for Health + Technology, University of Rochester, NY; Department of Clinical Neurosciences (K.M.S., R.W.), University of Cambridge, John van Geest Centre for Brain Repair, UK; Department of Pathology and Laboratory Medicine (V.M.V.D.), Center for Neurodegenerative Disease Research, Parelman School of Medicine at the University of Pennsylvania, Philadelphia; Genetics and Pharmacogenomics (A.G.D.-W.), Merck Research Laboratory, Boston, MA; Statistical Genetics (A.G.D.-W.), Biogen, Cambridge, MA; Institut du cerveau et de la moelle épinière ICM (A.B., F.D.); Sorbonne Université SU (A.B.); INSERM UMR (A.B.), Paris, France; Department of Neurology (G.A.), Stavanger University Hospital, Norway; Preventive Neurology Unit (A.J.N.), Wolfson Institute of Preventive Medicine, Queen Mary University of London; Department of Molecular Neuroscience (A.J.N.), UCL Institute of Neurology, London, UK; Department of Neurology (O.-B.T.), Haukeland University Hospital; University of Bergen (O.-B.T.), Bergen, Norway; Department of Neurology (J.R.E.), Nottingham University NHS Trust, UK; Centre for Clinical Brain Sciences (D.P.B.), University of Edinburgh; Anne Rowling Regenerative Neurology Clinic (D.P.B.), University of Edinburgh; Usher Institute of Population Health Sciences and Informatics (D.P.B.), University of Edinburgh, Scotland; Department of Medical and Molecular Genetics (C.E.W.), Indiana University, Indianapolis; Department of Neurology (D.K.S.), Beth Israel Deaconess Medical Center; Harvard Medical School (D.K.S.), Boston; Voyager Therapeutics (B.R.), Cambridge, MA; Department of Neurology (B.R.), University of Rochester School of Medicine, NY; Institute of Clinical Medicine (M.T.), University of Oslo, Norway; German Center for Neurodegenerative Diseases-Tubingen (P.H.); HIH Tuebingen (P.H.), Germany; Department of Psychiatry (D.W.), University of Pennsylvania School of Medicine; Department of Veterans Affairs (D.W.), Philadelphia, PA; and Department of Clinical Neurosciences (R.A.B., C.H.W.-G.), University of Cambridge, UK; Department of Neurology (J.J.V.H.), Leiden University Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659137PMC
August 2019

Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020-2116.

Amyotroph Lateral Scler Frontotemporal Degener 2019 05 9;20(3-4):264-274. Epub 2019 Apr 9.

a Department of Basic and Clinical Neuroscience , King's College London, Maurice Wohl Clinical Neuroscience Institute , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21678421.2019.1587629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567553PMC
May 2019

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease.

Front Neurol 2018 20;9:946. Epub 2018 Nov 20.

John van Geest Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2018.00946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256248PMC
November 2018

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis.

Front Neurol 2018 16;9:870. Epub 2018 Oct 16.

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2018.00870DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198066PMC
October 2018

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease.

Front Neurol 2018 1;9:815. Epub 2018 Oct 1.

Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2018.00815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176114PMC
October 2018

Targeting Aged Astrocytes May Be a New Therapeutic Strategy in Parkinson's Disease.

Mov Disord 2018 05 6;33(5):758-759. Epub 2018 Apr 6.

John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27387DOI Listing
May 2018

Evidence of an environmental effect on survival in ALS.

Amyotroph Lateral Scler Frontotemporal Degener 2014 Dec 27;15(7-8):528-33. Epub 2014 May 27.

King's College London Medical School , London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/21678421.2014.911326DOI Listing
December 2014

Prognostic categories for amyotrophic lateral sclerosis.

Amyotroph Lateral Scler 2012 Oct 7;13(6):502-8. Epub 2012 Jun 7.

MRC Centre for Neurodegeneration Research, King's College London, Institute of Psychiatry, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/17482968.2012.679281DOI Listing
October 2012

A proposed staging system for amyotrophic lateral sclerosis.

Brain 2012 Mar 23;135(Pt 3):847-52. Epub 2012 Jan 23.

MRC Centre for Neurodegeneration Research, King's College London, Institute of Psychiatry, London SE5 8AF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awr351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286327PMC
March 2012

No evidence for a large difference in ALS frequency in populations of African and European origin: a population based study in inner city London.

Amyotroph Lateral Scler 2012 Jan;13(1):66-8

Department of Neurology, Neuromuscular Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/17482968.2011.636049DOI Listing
January 2012

The risk to relatives of patients with sporadic amyotrophic lateral sclerosis.

Brain 2011 Dec 20;134(Pt 12):3454-7. Epub 2011 Sep 20.

MRC Centre for Neurodegeneration Research, Institute of Psychiatry P 041, London SE5 8AF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awr248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235555PMC
December 2011

Opsoclonus-myoclonus syndrome and HIV-infection.

J Neurol Sci 2009 Sep 5;284(1-2):192-5. Epub 2009 May 5.

King's College, London School of Medicine at Guy's, King's and St. Thomas's Hospitals, Registry, Henriette Raphael Building, Guy's Campus, SE11UL, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2009.04.026DOI Listing
September 2009

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.

Neuroepidemiology 2009 27;32(2):81-8. Epub 2008 Nov 27.

King's College Medical School at Guy's, King's College and St. Thomas's Hospitals, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000177032DOI Listing
December 2009

Corneal thickness at high altitude.

Cornea 2007 Apr;26(3):308-11

Sunderland Eye Infirmary, Sunderland, United Kingdom.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/ICO.0b013e31802e63c8DOI Listing
April 2007

What happens to intraocular pressure at high altitude?

Invest Ophthalmol Vis Sci 2007 Apr;48(4):1622-6

Tennent Institute of Ophthalmology, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.06-1238DOI Listing
April 2007